Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by the presence of the BCR-ABL1 fusion gene, leading to uncontrolled proliferation of myeloid cells. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.